Clinical trial
Bioavailability and Safety of Two Oral Fixed Dose Preparations Containing 18 mg Ivermectin (IVM 18 MG TABLETS, LICONSA S.A., Spain) Versus Reference Dosing (Weight Based) Containing 6 mg Ivermectin (REVECTINA, Abbott Laboratórios do Brasil Ltda, Brazil)
NCT03173742 is registered in ClinicalTrials.gov with Insud Pharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bioavailability and Safety of Two Oral Fixed Dose Preparations Containing 18 mg Ivermectin (IVM 18 MG TABLETS, LICONSA S.A., Spain) Versus Reference Dosing (Weight Based) Containing 6 mg Ivermectin (REVECTINA, Abbott Laboratórios do Brasil Ltda, Brazil)
- Lead sponsor
- Insud Pharma
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 31, 2016
- Completion date
- January 31, 2017
- Enrollment
- 54 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.